Not only do TAMs induce EMT in primary tumors, but can also secrete IL-35 in metastatic tumors to activate the JAK2–STAT6–GATA3 signaling pathway in cancer cells, which promotes MET and facilitates the colonization of cancer cells [43]. Here, JAK2 is linked to cancer.